Dr. Espinoza Gutarra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-297-9411
Education & Training
- National University of San MarcosClass of 2015
Certifications & Licensure
- AL State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2023 Jul 11
Roles: Principal Investigator
Publications & Presentations
PubMed
- US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for T...Pashna N Munshi, Rebecca L Olin, Sarah Wall, Shannon R McCurdy, Taha Al-Juhaishi
Transplantation and Cellular Therapy. 2025-02-15 - 1 citationsFactors Associated with Cancer Prevention/Risk Reduction Behaviors among Latinos.Susan M Rawl, Gerardo Maupome, Lilian Golzarri-Arroyo, Erik Parker, Heather A O'Leary
Journal of Racial and Ethnic Health Disparities. 2025-02-01 - Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.Kendall Diebold, Garrett Bourne, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia & Lymphoma. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: